 PURPOSE: This phase II trial is studying how well giving a reduced intensityusing Fludarabine, Busulfan and antithymocyte globulinpreparative regimen followed by donor stem cell transplant works in treating young patients with high-risk neuroblastoma that has relapsed or not responded to treatment. 